NCT01607593View on ClinicalTrials.gov

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

sertraline (Zoloft)

Dosage form: Tablet, Dosage: over 25 mg/day, duration: Not defined

Trial Locations (4)

Unknown

KURUME University School of Medicine, Kurume

Hyogo Institute for Traumatic Stress, Chuo-ku,Kobe-city

National Defense Medical College/Department of Psychiatry, Tokorozawa

Institute of Women?s Health Tokyo Women?s Medical University, Shinjyuku-ku

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01607593 - A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients | Biotech Hunter | Biotech Hunter